NCT02297516View on ClinicalTrials.gov

Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Aesthetics
Interventions
DRUG

Azzalure or Dysport

Glabellar lines

DEVICE

Restylane or Emervel filler

Facial tissue augmentation

DEVICE

Restylane Skinbooster

Facial skin rejuvenation

Trial Locations (4)

62000

Centre Medical Saint-Jean, Arras

90570-040

Brazilian Center for Studies in Dermatology, Porto Alegre

06160

Mediti Center, Paris

115 42

Akademikliniken, Stockholm

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY